Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG GENES KEGG PATHWAY KEGG DRUG DrugBank 指定難病告示番号
1 HDAC6 1件: Viral carcinogenesis D06320 Vorinostat 3件: 19, 75, 96
2 HDAC5 1件: Viral carcinogenesis D06320 Vorinostat 3件: 19, 75, 96
3 CDK4 1件: Viral carcinogenesis D10688 Abemaciclib 1件: 34
4 CDK6 1件: Viral carcinogenesis D10688 Abemaciclib 1件: 34
5 CCR4 2件: Viral protein interaction with cytokine and cytokine receptor, Viral carcinogenesis D09761 Mogamulizumab 1件: 26
6 CCR5 2件: Viral protein interaction with cytokine and cytokine receptor, Viral carcinogenesis D06670 Maraviroc 2件: 46, 84
7 CCR5 2件: Viral protein interaction with cytokine and cytokine receptor, Viral carcinogenesis D09878 Cenicriviroc 1件: 94
8 HDAC1 1件: Viral carcinogenesis D06320 Vorinostat 3件: 19, 75, 96
9 HDAC2 1件: Viral carcinogenesis D06320 Vorinostat 3件: 19, 75, 96
10 HLA-A 2件: Viral carcinogenesis, Viral myocarditis D04318 Glatiramer 4件: 2, 13, 96, 156
11 HLA-B 2件: Viral carcinogenesis, Viral myocarditis D04318 Glatiramer 4件: 2, 13, 96, 156
12 HLA-C 2件: Viral carcinogenesis, Viral myocarditis D04318 Glatiramer 4件: 2, 13, 96, 156
13 HLA-E 2件: Viral carcinogenesis, Viral myocarditis D04318 Glatiramer 4件: 2, 13, 96, 156
14 HLA-F 2件: Viral carcinogenesis, Viral myocarditis D04318 Glatiramer 4件: 2, 13, 96, 156
15 HLA-G 2件: Viral carcinogenesis, Viral myocarditis D04318 Glatiramer 4件: 2, 13, 96, 156
16 JAK1 1件: Viral carcinogenesis D09959 Ruxolitinib 1件: 228
17 JAK1 1件: Viral carcinogenesis D09970 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 256, 271
18 JAK1 1件: Viral carcinogenesis D10308 Baricitinib 13件: 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 268, 269, 325
19 JAK1 1件: Viral carcinogenesis D10653 Peficitinib 1件: 46
20 JAK1 1件: Viral carcinogenesis D10871 Filgotinib 6件: 46, 53, 96, 97, 222, 271
21 JAK1 1件: Viral carcinogenesis D10944 Itacitinib 5件: 46, 51, 60, 97, 228
22 JAK1 1件: Viral carcinogenesis D10994 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271
23 JAK3 1件: Viral carcinogenesis D09970 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 256, 271
24 JAK3 1件: Viral carcinogenesis D10653 Peficitinib 1件: 46
25 NFKB1 2件: Yersinia infection, Viral carcinogenesis D01146 Iguratimod 4件: 46, 51, 53, 271
26 HDAC7 1件: Viral carcinogenesis D06320 Vorinostat 3件: 19, 75, 96
27 PIK3CA 2件: Yersinia infection, Viral carcinogenesis D11158 Leniolisib 2件: 53, 65
28 PIK3CB 2件: Yersinia infection, Viral carcinogenesis D11158 Leniolisib 2件: 53, 65
29 PIK3CD 2件: Yersinia infection, Viral carcinogenesis D11158 Leniolisib 2件: 53, 65
30 PIK3CD 2件: Yersinia infection, Viral carcinogenesis D11437 Parsaclisib 3件: 35, 53, 61
31 HDAC8 1件: Viral carcinogenesis D06320 Vorinostat 3件: 19, 75, 96
32 RELA 2件: Yersinia infection, Viral carcinogenesis D12181 Edasalonexent 1件: 113
33 SRC 2件: Yersinia infection, Viral carcinogenesis D03252 Bosutinib 2件: 2, 67
34 SRC 2件: Yersinia infection, Viral carcinogenesis D03658 Dasatinib 2件: 51, 85
35 SRC 2件: Yersinia infection, Viral carcinogenesis D06414 Dasatinib 2件: 51, 85
36 SRC 2件: Yersinia infection, Viral carcinogenesis D09664 Saracatinib 3件: 6, 89, 272
37 SYK 1件: Viral carcinogenesis D09347 Fostamatinib 4件: 46, 49, 61, 66
38 C3 1件: Viral carcinogenesis D11613 Pegcetacoplan 3件: 2, 62, 222
39 HDAC11 1件: Viral carcinogenesis D06320 Vorinostat 3件: 19, 75, 96
40 HDAC10 1件: Viral carcinogenesis D06320 Vorinostat 3件: 19, 75, 96
41 HDAC3 1件: Viral carcinogenesis D06320 Vorinostat 3件: 19, 75, 96
42 HDAC9 1件: Viral carcinogenesis D06320 Vorinostat 3件: 19, 75, 96
43 HDAC4 1件: Viral carcinogenesis D06320 Vorinostat 3件: 19, 75, 96